Filter Search for grants
Call Navigation
Call key data
Call for proposals to pilot and implement cancer screening programmes for prostate cancer
Funding Program
EU4Health programme 2021-2027
Call number
EU4H-2026-SANTE-PJ-03
deadlines
Opening
23.09.2025
Deadline
06.01.2026 17:00
Funding rate
60%
Call budget
€ 7,440,000.00
Estimated EU contribution per project
€ 7,440,000.00
Link to the call
Link to the submission
Call content
short description
This action will contribute to the implementation of prostate cancer screening programmes, in a stepwise approach to ensure the gradual and appropriate planning, piloting, and roll-out of the screening programmes within national priorities, as called for in the 2022 Council Recommendation and upcoming European Guidelines on cancer screening. The use of AI in ongoing (pilot) programmes shall be assessed, and the potential use of AI, where feasible, further be explored. Synergies with actions implementing the European Cancer Imaging Initiative, in particular the Cancer Image Europe platform, shall be explored. Potential synergies with the project stemming out of the “Call for proposals on advancing the adoption of artificial intelligence in health” (DI-g-24-76 from 2024 EU4Health work programme) shall be explored.
Call objectives
The action may include the following activities:
- facilitating implementation research via new pilots and programme rollout initiatives through:
- monitoring and assessment of on-going implementation studies;
- defining needs for and planning of new implementation studies based on gap analyses, building on deliverables of the PRAISE-U project;
- supporting, coordinating and running implementation studies within Member States;
- linking regional/national implementations studies within Member States to reduce duplication and human/financial resources as well as to increase study impact;
- regular quality assessment and improvement of implementation research.
- facilitating aggregation and analysis of the prostate cancer imaging datasets, allowing cross-border multi-centric cooperation on AI studies, including research and development of replicable AI algorithms for prostate cancer screening and for strengthening the evidence base for AI uptake in prostate cancer screening programmes
- collection and assessment of benefits/harms data and other data on outcomes, quality assurance and cost-effectiveness relating to prostate cancer screening programmes from the national level based on the established methods, infrastructure and networks within the previous EU4Health Programme funded projects.
- linking relevant experts and representatives from European medical societies and patient organisations to ensure broad outreach to corresponding national partner societies and patient organisations.
- effective dissemination as well as bidirectional knowledge exchange with all Member States and relevant candidate countries relating to prostate cancer screening.
- close collaboration with related projects, such as those covering lung and gastric cancer screening, and the Joint Action Implementation of cancer screening programmes (‘EUCanScreen’) from the 2023 EU4Health work programme action CR-g-23-38.
- close collaboration with the Commission’s Joint Research Centre, and the planned Commission Initiative on Prostate Cancer.
- exploration of the potential of artificial intelligence (AI) in prostate cancer screening to detect prostate cancer at an earlier stage and reduce disparities in access to diagnosis among high-risk populations in synergy with the activities under the European Cancer Imaging Initiative.
read more
Expected results
The expected results and impact are:
- regularly updated reporting and gap analysis to guide Member States;
- enhanced knowledge on the current state of play and feasible and successful modalities of prostate cancer screening programmes, including the integration of new AI-based screening technologies to improve detection and reduce disparities across Member States;
- further roll-out of prostate cancer screening;
- further availability of prostate cancer screening programmes across the Union based on European Guidelines, as available.
Eligibility Criteria
Regions / countries for funding
Moldova (Moldova), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Iceland (Ísland), Montenegro (Црна Гора), Norway (Norge), Ukraine (Україна)
eligible entities
Education and training institution, International organization, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), Other, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Research Institution incl. University, Small and medium-sized enterprise (SME)
Mandatory partnership
Yes
Project Partnership
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs))
- listed EEA countries and countries associated to the EU4Health Programme (list of participating countries)
Proposals must be submitted by a consortium of at least 5 beneficiaries from 5 different eligible countries.
other eligibility criteria
Specific cases
- Natural persons are NOT eligible (with the exception of self-employed persons, i.e. sole traders, where the company does not have legal personality separate from that of the natural person).
- International organisations are eligible. The rules on eligible countries do not apply to them.
- Entities which do not have legal personality under their national law may exceptionally participate, provided that their representatives have the capacity to undertake legal obligations on their behalf, and offer guarantees for the protection of the EU financial interests equivalent to that offered by legal persons
- EU bodies (with the exception of the European Commission Joint Research Centre) can NOT be part of the consortium.
- Associations and interest groupings - entities composed of members may participate as ‘sole beneficiaries’ or ‘beneficiaries without legal personality’. Please note that if the action will be implemented by the members, they should also participate (either as beneficiaries or as affiliated entities, otherwise their costs will NOT be eligible).
- European Reference Networks (ERNs) — These cover networks between healthcare providers and centres of expertise in the Member States to reinforce healthcare cooperation, in particular in the area of rare diseases, in line with the objectives set out in Article 12 of Directive 2011/24.
- Countries currently negotiating association agreements — Beneficiaries from countries with ongoing negotiations for participation in the programme (see list of participating countries) may participate in the call and can sign grants if the negotiations are concluded before grant signature and if the association covers the call (i.e. is retroactive and covers both the part of the programme and the year when the call was launched).
- EU restrictive measures — Special rules apply for entities subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU). Such entities are not eligible to participate in any capacity, including as beneficiaries, affiliated entities, associated partners, subcontractors or recipients of financial support to third parties (if any).
- EU conditionality measures — Special rules apply for entities subject to measures adopted on the basis of EU Regulation 2020/209214. Such entities are not eligible to participate in any funded role (beneficiaries, affiliated entities, subcontractors, recipients of financial support to third parties, etc). Currently such measures are in place for Hungarian public interest trusts established under the Hungarian Act IX of 2021 or any entity they maintain (see Council Implementing Decision (EU) 2022/2506, as of 16 December 2022).
Additional information
Topics
Relevance for EU Macro-Region
EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region
UN Sustainable Development Goals (UN-SDGs)
project duration
max. 36 months
Additional Information
Proposals must be submitted electronically via the Funding & Tenders Portal Electronic Submission System. Paper submissions are NOT possible.
Proposals must be complete and contain all the requested information and all required annexes and supporting documents:
- Application Form Part A — contains administrative information about the participants (future coordinator, beneficiaries and affiliated entities) and the summarised budget for the project (to be filled in directly online)
- Application Form Part B — contains the technical description of the project (template to be downloaded from the Portal Submission System, completed, assembled and re-uploaded)
- mandatory annexes and supporting documents (templates to be downloaded from the Portal Submission System, completed, assembled and re-uploaded):
- detailed budget table/calculator
- CVs (standard) of core project team
- list of previous projects (key projects for the last 4 years) (template available in Part B)
Proposals are limited to maximum 70 pages (Part B).
Financial support to third parties is not allowed.
Call documents
Call Document EU4H-2026-SANTE-PJCall Document EU4H-2026-SANTE-PJ(1036kB)
Contact
Website
HaDEA- EU4 Health
HaDEA-HP-CALLS@ec.europa.eu
Website
To see more information about this call, you can register for free here
or log in with an existing account.
Log in
Register now